What type of study is this?

October 18, 2025Hypertension

Abstract FR414: Malignant Hypertension as a Rare Cause of Thrombotic Microangiopathy and Microangiopathic Hemolytic Anemia

View Full Paper

Ask AI

Bookmark

Malignant hypertension can lead to both thrombotic microangiopathy and microangiopathic hemolytic anemia, necessitating quick intervention.
Patient treatment included plasmapheresis and multiple antihypertensive medications, revealing the severity of the hypertension's impact.
Diagnosis was confirmed through renal biopsy showing thrombotic microangiopathic changes and focal glomerulosclerosis.
Accurate identification of malignant hypertension is crucial to prevent unnecessary treatments and irreversible organ damage.

No takes yet. Share an insight, caveat, or question.

Case report details malignant hypertension causing thrombotic microangiopathy and hemolytic anemia, indicating urgent BP control is essential.

Kozyra et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case report details malignant hypertension causing thrombotic microangiopathy and hemolytic anemia, indicating urgent BP control is essential.